Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/41613| Title: | Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies, 2014. | Authors: | Dendle C. ;Wolf J.;Teh B.W.;Chen S.C.;Cooley L.;Boutlis C.;Thursky K.A. | Monash Health Department(s): | Infectious Diseases and Clinical Microbiology | Institution: | (Cooley) Department of Microbiology and Infectious Diseases, Royal Hobart Hospital, Hobart, TAS, Australia (Dendle) Departments of Infectious Diseases and General Medicine, Monash Medical Centre, Monash Health, Clayton, VIC, Australia (Dendle) Southern Clinical School, Faculty of Medicine, Monash University, Melbourne, VIC, Australia (Wolf) Department of Infectious Diseases, St. Jude Children's Research Center, Memphis, TN, United States (Wolf) University of Tennessee Health Sciences Center, Memphis, TN, United States (Teh, Thursky) Department of Infectious Diseases and Infection Control, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia (Chen) Centre for Infectious Diseases and Microbiology Laboratory Services, ICPMR - Pathology West, Westmead, NSW, Australia (Chen) Department of Infectious Diseases, Westmead Hospital, Westmead, NSW, Australia (Chen) Sydney Medical School, The University of Sydney, Sydney, NSW, Australia (Boutlis) Department of Infectious Diseases, Wollongong Hospital, Wollongong, NSW, Australia (Boutlis) Graduate School of Medicine, University of Wollongong, Wollongong, NSW, Australia (Thursky) Victorian Infectious Diseases Service, The Doherty Institute for Infection and Immunity, Parkville, VIC, Australia | Issue Date: | 1-Feb-2015 | Copyright year: | 2014 | Publisher: | Blackwell Publishing | Place of publication: | Australia | Publication information: | Internal Medicine Journal. Part B. 44 (12) (pp 1350-1363), 2014. Date of Publication: 01 Dec 2014. | Journal: | Internal Medicine Journal | Abstract: | Pneumocystis jirovecii infection (PJP) is a common cause of pneumonia in patients with cancer-related immunosuppression. There are well-defined patients who are at risk of PJP due to the status of their underlying malignancy, treatment-related immunosuppression and/or concomitant use of corticosteroids. Prophylaxis is highly effective and should be given to all patients at moderate to high risk of PJP. Trimethoprim-sulfamethoxazole is the drug of choice for prophylaxis and treatment, although several alternative agents are available.Copyright © 2014 The Authors; Internal Medicine Journal © 2014 Royal Australasian College of Physicians. | DOI: | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1111/imj.12599 | PubMed URL: | 25482745 [http://www.ncbi.nlm.nih.gov/pubmed/?term=25482745] | ISSN: | 1444-0903 | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/41613 | Type: | Review | Type of Clinical Study or Trial: | Review article (e.g. literature review, narrative review) |
| Appears in Collections: | Articles |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.